BlackRock buys blood bank and pharmaceutical lab for new platform
Global investment giant BlackRock and local fund manager Wentworth Capital have acquired a Red Cross blood-processing facility in Alexandria and a pharmaceutical laboratory in Macquarie Park as the first seed assets for a $1.5 billion Life Sciences investment platform.
The acquisitions follow the JV partners identifying life sciences – an emerging alternative real estate sector that includes laboratories and research hubs – as a sought-after asset class by global institutional investors and Australia as a market offering attractive buying opportunities.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Commercial
Fetching latest articles